Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Chantal Reusken; M Niedrig; Suzan Pas; P Anda; S Baize; R Charrel; A Di Caro; C Drosten; MD Fernandez-Garcia; L Franco; S Gunther; I Leparc-Goffart; Byron Martina; D Pannetier; A Papa; MP Sanchez-Seco; O Vapalahti; Marion Koopmans

doi:10.1016/j.jcv.2014.11.007

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Chantal Reusken, M Niedrig, Suzan Pas, P Anda, S Baize, R Charrel, A Di Caro, C Drosten, MD Fernandez-Garcia, L Franco, S Gunther, I Leparc-Goffart, Byron Martina, D Pannetier, A Papa, MP Sanchez-Seco, O Vapalahti, Marion Koopmans

Virology

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Abstract

On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease(EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made. (C) 2014 Elsevier B.V. All rights reserved.

Original language	Undefined/Unknown
Pages (from-to)	124-134
Number of pages	11
Journal	Journal of Clinical Virology
Volume	62
DOIs	https://doi.org/10.1016/j.jcv.2014.11.007
Publication status	Published - 2015

Research programs

EMC MM-04-27-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jcv.2014.11.007

Cite this

Reusken, C., Niedrig, M., Pas, S., Anda, P., Baize, S., Charrel, R., Di Caro, A., Drosten, C., Fernandez-Garcia, MD., Franco, L., Gunther, S., Leparc-Goffart, I., Martina, B., Pannetier, D., Papa, A., Sanchez-Seco, MP., Vapalahti, O., & Koopmans, M. (2015). Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. Journal of Clinical Virology, 62, 124-134. https://doi.org/10.1016/j.jcv.2014.11.007

@article{e2a275ebd9304f13a903890201ecf77a,

title = "Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014",

abstract = "On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease(EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of {"}Imported{"} Viral Diseases{"}, ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made. (C) 2014 Elsevier B.V. All rights reserved.",

author = "Chantal Reusken and M Niedrig and Suzan Pas and P Anda and S Baize and R Charrel and {Di Caro}, A and C Drosten and MD Fernandez-Garcia and L Franco and S Gunther and I Leparc-Goffart and Byron Martina and D Pannetier and A Papa and MP Sanchez-Seco and O Vapalahti and Marion Koopmans",

year = "2015",

doi = "10.1016/j.jcv.2014.11.007",

language = "Undefined/Unknown",

volume = "62",

pages = "124--134",

journal = "Journal of Clinical Virology",

issn = "1386-6532",

publisher = "Elsevier",

}

Reusken, C, Niedrig, M, Pas, S, Anda, P, Baize, S, Charrel, R, Di Caro, A, Drosten, C, Fernandez-Garcia, MD, Franco, L, Gunther, S, Leparc-Goffart, I, Martina, B, Pannetier, D, Papa, A, Sanchez-Seco, MP, Vapalahti, O & Koopmans, M 2015, 'Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014', Journal of Clinical Virology, vol. 62, pp. 124-134. https://doi.org/10.1016/j.jcv.2014.11.007

TY - JOUR

T1 - Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

AU - Reusken, Chantal

AU - Niedrig, M

AU - Pas, Suzan

AU - Anda, P

AU - Baize, S

AU - Charrel, R

AU - Di Caro, A

AU - Drosten, C

AU - Fernandez-Garcia, MD

AU - Franco, L

AU - Gunther, S

AU - Leparc-Goffart, I

AU - Martina, Byron

AU - Pannetier, D

AU - Papa, A

AU - Sanchez-Seco, MP

AU - Vapalahti, O

AU - Koopmans, Marion

PY - 2015

Y1 - 2015

N2 - On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease(EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made. (C) 2014 Elsevier B.V. All rights reserved.

AB - On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease(EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made. (C) 2014 Elsevier B.V. All rights reserved.

U2 - 10.1016/j.jcv.2014.11.007

DO - 10.1016/j.jcv.2014.11.007

M3 - Article

C2 - 25692204

SN - 1386-6532

VL - 62

SP - 124

EP - 134

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

ER -